Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98


HLA-F is a surface marker on activated lymphocytes.

Lee N, Ishitani A, Geraghty DE.

Eur J Immunol. 2010 Aug;40(8):2308-18.


Lack of HLA-class I antigens in human neuroblastoma cells: analysis of its relationship to TAP and tapasin expression.

Corrias MV, Occhino M, Croce M, De Ambrosis A, Pistillo MP, Bocca P, Pistoia V, Ferrini S.

Tissue Antigens. 2001 Feb;57(2):110-7.


Fetal-maternal HLA-C mismatch is associated with decidual T cell activation and induction of functional T regulatory cells.

Tilburgs T, Scherjon SA, van der Mast BJ, Haasnoot GW, Versteeg-V D Voort-Maarschalk M, Roelen DL, van Rood JJ, Claas FH.

J Reprod Immunol. 2009 Nov;82(2):148-57. doi: 10.1016/j.jri.2009.05.003. Epub 2009 Jul 23.


CD2 costimulation reveals defective activity by human CD4+CD25(hi) regulatory cells in patients with multiple sclerosis.

Baecher-Allan CM, Costantino CM, Cvetanovich GL, Ashley CW, Beriou G, Dominguez-Villar M, Hafler DA.

J Immunol. 2011 Mar 15;186(6):3317-26. doi: 10.4049/jimmunol.1002502. Epub 2011 Feb 7.


Interaction with activated monocytes enhances cytokine expression and suppressive activity of human CD4+CD45ro+CD25+CD127(low) regulatory T cells.

Walter GJ, Evans HG, Menon B, Gullick NJ, Kirkham BW, Cope AP, Geissmann F, Taams LS.

Arthritis Rheum. 2013 Mar;65(3):627-38. doi: 10.1002/art.37832.


Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells.

Selmani Z, Naji A, Zidi I, Favier B, Gaiffe E, Obert L, Borg C, Saas P, Tiberghien P, Rouas-Freiss N, Carosella ED, Deschaseaux F.

Stem Cells. 2008 Jan;26(1):212-22. Epub 2007 Oct 11.


HLA-E: strong association with beta2-microglobulin and surface expression in the absence of HLA class I signal sequence-derived peptides.

Lo Monaco E, Sibilio L, Melucci E, Tremante E, Suchànek M, Horejsi V, Martayan A, Giacomini P.

J Immunol. 2008 Oct 15;181(8):5442-50.


HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes.

Romagnani C, Pietra G, Falco M, Mazzarino P, Moretta L, Mingari MC.

Hum Immunol. 2004 May;65(5):437-45.


Differential contribution of TAP and tapasin to HLA class I antigen expression.

Belicha-Villanueva A, McEvoy S, Cycon K, Ferrone S, Gollnick SO, Bangia N.

Immunology. 2008 May;124(1):112-20. doi: 10.1111/j.1365-2567.2007.02746.x. Epub 2008 Jan 11.


Distinct functions of tapasin revealed by polymorphism in MHC class I peptide loading.

Peh CA, Laham N, Burrows SR, Zhu Y, McCluskey J.

J Immunol. 2000 Jan 1;164(1):292-9.


Soluble HLA class I molecules/CD8 ligation trigger apoptosis of CD8+ cells by Fas/Fas-ligand interaction.

Puppo F, Contini P, Ghio M, Indiveri F.

ScientificWorldJournal. 2002 Feb 12;2:421-3. Review.


Induction of cell surface human leukocyte antigen-G expression in pandemic H1N1 2009 and seasonal H1N1 influenza virus-infected patients.

Chen HX, Chen BG, Shi WW, Zhen R, Xu DP, Lin A, Yan WH.

Hum Immunol. 2011 Feb;72(2):159-65. doi: 10.1016/j.humimm.2010.11.009. Epub 2010 Nov 16.


HCMV glycoprotein US6 mediated inhibition of TAP does not affect HLA-E dependent protection of K-562 cells from NK cell lysis.

Ulbrecht M, Hofmeister V, Yüksekdag G, Ellwart JW, Hengel H, Momburg F, Martinozzi S, Reboul M, Pla M, Weiss EH.

Hum Immunol. 2003 Feb;64(2):231-7.


Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.

Mitsdoerffer M, Schreiner B, Kieseier BC, Neuhaus O, Dichgans J, Hartung HP, Weller M, Wiendl H.

J Neuroimmunol. 2005 Feb;159(1-2):155-64. Epub 2004 Dec 28.


Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.

Brillard E, Pallandre JR, Chalmers D, Ryffel B, Radlovic A, Seilles E, Rohrlich PS, Pivot X, Tiberghien P, Saas P, Borg C.

Exp Hematol. 2007 Mar;35(3):416-25.


HLA-E surface expression is independent of the availability of HLA class I signal sequence-derived peptides in human tumor cell lines.

Palmisano GL, Contardi E, Morabito A, Gargaglione V, Ferrara GB, Pistillo MP.

Hum Immunol. 2005 Jan;66(1):1-12.


CTLA-4 blockade following relapse of malignancy after allogeneic stem cell transplantation is associated with T cell activation but not with increased levels of T regulatory cells.

Zhou J, Bashey A, Zhong R, Corringham S, Messer K, Pu M, Ma W, Chut T, Soiffer R, Mitrovich RC, Lowy I, Ball ED.

Biol Blood Marrow Transplant. 2011 May;17(5):682-92. doi: 10.1016/j.bbmt.2010.08.005. Epub 2010 Aug 14.

Supplemental Content

Support Center